JENBURKT PHARMACEUTICALS
|
The Current P/E Ratio of JENBURKT PHARMACEUTICALS is 17.24.
Share Price | ₹1,187.5 | Nov 12,2024 |
Market Cap | ₹522.5 Cr | |
Earnings-TTM | ₹30.3 Cr | TTM-Standalone Results |
Price/Earnings | 17.24x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of JENBURKT PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹522.5 Cr] as on Nov 12,2024
(/) Earnings [ ₹30.3 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 17.24x ]
Thus, for JENBURKT PHARMACEUTICALS , the investors are currently willing to pay 17.24 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of JENBURKT PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of JENBURKT PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of JENBURKT PHARMACEUTICALS
PE Ratio Performance Analysis for JENBURKT PHARMACEUTICALS
- JENBURKT PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 11.24x.
- JENBURKT PHARMACEUTICALS 's operated at median p/e ratio of 11.66x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, JENBURKT PHARMACEUTICALS 's p/e ratio peaked in Mar2023 at 11.94x.
- JENBURKT PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 9.81x.
How does JENBURKT PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
JENBURKT PHARMACEUTICALS | 30.30 | 17.24 | 522.5 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,136.50 | 38.78 | 431,844.0 |
CIPLA LTD | 4,485.22 | 27.45 | 123,138.0 |
DR REDDYS LABORATORIES LTD | 5,406.80 | 19.49 | 105,391.0 |
ZYDUS LIFESCIENCES LTD | 4,298.90 | 22.24 | 95,602.3 |
DIVIS LABORATORIES LTD | 1,836.00 | 83.96 | 154,155.0 |
MANKIND PHARMA LTD | 2,124.86 | 49.56 | 105,308.0 |
TORRENT PHARMACEUTICALS LTD | 1,802.00 | 59.17 | 106,629.0 |
LUPIN LTD | 2,651.94 | 35.92 | 95,255.8 |
AUROBINDO PHARMA LTD | 3,598.83 | 20.45 | 73,610.8 |
ABBOTT INDIA LTD | 1,284.66 | 47.33 | 60,799.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs JENBURKT PHARMACEUTICALS 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 17.24x |
Max industry PE | 83.96x |
Median industry PE | 35.92x |
Average industry PE | 38.33x |
You may also like the below Video Courses